The correlation between prion disease and AD was further extended by the finding that the clinically approved AChE inhibitor donepezil restored the learning and memory deficit in prion disease, indicating that diminished cholinergic transmission was mechanistically linked to the memory loss observed in prion disease. The gene discussed is ACHE; the disease is prion disease.